Suchergebnisse - "Receptors, Antigen, T-Cell"

PubPharm (42.107)

1

Pathways and mechanisms of CD4+CD8αα+ intraepithelial T cell development

enthalten in: Trends in immunology | 2024

von Li, C. | Lanasa, D. | Park, J.

2

Antigen/HLA-agnostic strategies for Characterizing Tumor-responsive T cell receptors in PDAC patients via single-cell sequencing and autologous organoid application

enthalten in: Cancer letters | 2024

von Wang, X. | Dai, Z. | Lin, X. | +9

3

Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killing

enthalten in: Cellular & molecular immunology | 2024

von Wu, Z. | Lamao, Q. | Gu, M. | +10

4

Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Wang, Y. | Huang, Z. | Li, B. | +26

5

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma : ELARA trial update

enthalten in: Blood | 2024

von Dreyling, M. | Fowler, N. | Dickinson, M. | +37

6

Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective

enthalten in: Bone marrow transplantation | 2024

von Ahmadi, P. | Ghandili, S. | Jakobs, F. | +4

7

Correlation of T-cell receptor constant beta-chain 1 by flow cytometry with molecular T-cell receptor clonality for the investigation of T-cell lymphoproliferation

enthalten in: British journal of haematology | 2024

von Dexter, T. | Taiwo, T. | Dearden, C. | +5

8

The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for Lymphoma

enthalten in: Seminars in oncology nursing | 2024

von Andersen, L. | Baker, K. | Difilippo, H. | +3

9

CAR T-Cells and Safety Signals : ITT Episode 29

enthalten in: The New England journal of medicine | 2024

10

CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia

enthalten in: The New England journal of medicine | 2024

von Blaise, D.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[4211]